Landscapes / Targets
orthogonal IL-2 receptor (hoRb)
1 drug acts on orthogonal IL-2 receptor (hoRb), in 2 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs1
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | Apr 2028Phase 1 trial completes | |||
| Next date | Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | CLL/SLL, NHL and 8 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 1 of 1 drug. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026